Methotrexate-γ-aspartate

• Description:

  Methotrexate-γ-aspartate is a Ll210 cell dihydrofolate reductase inhibitor. Methotrexate-γ-aspartate is apparently more resistant to enzymic cleavage than is methotrexate-y-glutamate. Methotrexate-γ-aspartate can be used in antibody-targeted liposomes and is promising for research of leukemic[1].

• UNSPSC:

  12352005

• Target:

  Dihydrofolate reductase (DHFR)

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/methotrexate-γ-aspartate.html

• Smiles:

  NC1=NC (N) =NC2=C1N=C (CN (C3=CC=C (C=C3) C (N[C@H] (C (O) =O) CCC (N[C@H] (C (O) =O) CC (O) =O) =O) =O) C) C=N2

• Molecular Formula:

  C24H27N9O8

• Molecular Weight:

  569.53

• References & Citations:

  [1]Sirotnak FM, et al. Growth inhibitory, transport and biochemical properties of the gamma-glutamyl and gamma-aspartyl peptides of methotrexate in L1210 leukemia cells in vitro. Biochem Pharmacol. 1978;27 (14) :1821-5.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  64801-58-7